Prophylactic human papillomavirus (HPV) vaccine represents a revolutionary step forward in
preventing HPV-related cancers, especially cervical carcinoma. Alongside appropriate …

While two prophylactic HPV vaccines have been proven notably efficacious in clinical trials,
the effectiveness of these vaccines at the population level remains to be evaluated. To lay …

Abstract Background The Human Papillomavirus (HPV) is generally recognized to be the
direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in …

Background A phase 3 trial was conducted to evaluate the efficacy of a prophylactic
quadrivalent vaccine in preventing anogenital diseases associated with human …

Background Human papillomavirus (HPV) is one of the most common sexually transmitted
infections worldwide. Although the efficacy of the HPV vaccine in preventing the …

Human papillomavirus (HPV) is a DNA virus that causes a variety of conditions including
common warts, condyloma acuminata (anogenital warts), and multiple malignancies …

ABSTRACT A systematic literature review was conducted to describe in a historical
perspective the evolution of studies concerning HPV vaccination. The search identified 794 …

Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …

In high income setting, the massive implementation of screening programs has reduced the
incidence of cervical cancer, dramatically. However, cervical cancer still remains a major …

Introduction Human papillomavirus (HPV) is a causal agent of malignancies including
cervical, vulvar, vaginal, penile, anal and oropharyngeal cancer, as well as benign …